Question Everything. See who's reporting it.

Maharashtra FDA Withdraws Cipla Drug Licence Cancellation After Bombay HC Rebuke

Source: Free Press Journal

The story in brief

The Bombay High Court ruled the Maharashtra FDA's procedure violated natural justice principles after it cancelled Cipla's drug licence over alleged compliance issues with Reactin Plus Tablets. The regulator withdrew the cancellation order and issued a fresh show-cause notice following the court's intervention, which questioned the fairness of holding the company on a public holiday without adjournment.

2 outletsSee what the other 1 outlet said

NEWXFree on Android and iPhone. Open in NEWX